Related Experiment Video
Updated: Feb 8, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Triple Therapy: When, if Ever?
Nino Mihatov1, Eric A Secemsky1, Sammy Elmariah2
1Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, GRB 8-800, Boston, MA, 02114, USA.
Insights
For patients needing both anticoagulation and stenting, shorter durations of triple therapy (dual antiplatelet therapy and oral anticoagulation) followed by dual therapy with oral anticoagulation and a P2Y12 inhibitor appear safe and effective.
Area of Science:
- Cardiology
- Interventional Cardiology
- Pharmacology
Background:
- Over 9% of patients undergoing percutaneous coronary intervention (PCI) require long-term oral anticoagulation (OAC).
- Optimal antithrombotic strategies for these high-risk patients remain unclear.
- Dual antiplatelet therapy (DAPT) excels at preventing stent-related events, while OAC is superior for atrial fibrillation thromboembolism prevention.
Purpose of the Study:
- To review current evidence on the safety and efficacy of dual therapy (OAC + P2Y12 inhibitor) versus triple therapy (DAPT + OAC) in stented patients requiring long-term anticoagulation.
- To evaluate strategies involving shorter durations of triple therapy followed by dual therapy.
Main Methods:
- Review of numerous studies comparing different antithrombotic regimens.
- Analysis of data on stent-related events, thromboembolism, and bleeding risks.
- Focus on recent findings regarding abbreviated triple therapy durations.
Main Results:
- Triple therapy significantly increases bleeding risk (up to threefold) compared to warfarin monotherapy.
- Shorter durations of triple therapy followed by dual therapy (OAC + P2Y12 inhibitor) have shown promising safety profiles.
- Evidence supports the efficacy of OAC in preventing thromboembolism in atrial fibrillation patients.
Conclusions:
- Dual therapy with OAC and a P2Y12 inhibitor offers a potentially safer alternative to prolonged triple therapy.
- Optimizing antithrombotic strategies involves balancing the prevention of thrombotic events with minimizing bleeding complications.
- Further research is needed to establish definitive guidelines for managing these complex patients.
Purpose Of Review:
More than 9% of patients who undergo percutaneous coronary intervention (PCI) carry a concomitant indication for long-term anticoagulation (OAC). The optimal combination of anticoagulation and antiplatelet therapy for these patients remains uncertain.
Recent Findings:
Numerous studies have demonstrated that dual antiplatelet therapy (DAPT) remains superior to vitamin K antagonists (VKA) in the prevention of stent-related events. Nonetheless, OAC therapy is more efficacious than DAPT at reducing thromboembolism in patients with atrial fibrillation. The combination of DAPT and OAC, known as triple therapy, portends as much as a threefold increased risk of fatal and nonfatal bleeding compared to warfarin monotherapy. Recent studies have demonstrated the safety of shorter durations of triple therapy with subsequent transition to a P2Y12 inhibitor in combination with an OAC. Here, we review the evidence regarding the safety and efficacy of dual therapy with OAC in combination with a P2Y12 inhibitor versus triple therapy among recently stented patients with a long-term requirement for OAC.
Related Concept Videos
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

